Percutaneous injection sclerotherapy with tetracycline hydrochloride in simple renal cysts

Basit Öğe Kaydı
dc.contributor.authorKilinc, Mehmet
dc.contributor.authorTufan, Osman
dc.contributor.authorGuven, Selcuk
dc.contributor.authorOdev, Kemal
dc.contributor.authorGurbuz, Recai
dc.date.accessioned2020-03-26T17:27:25Z
dc.date.available2020-03-26T17:27:25Z
dc.date.issued2008
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractObjectives Symptomatic simple renal cysts can be treated by combination of percutaneous aspiration and sclerotherapy. A number of sclerosing agents including glucose, phenol, iophendylate, polidocanol, minocycline and pantopaque have been used in the past to prevent reformation of cyst. In this study, tetracycline HCL solution is evaluated as a sclerosant for treatment of simple renal cysts. Methods Our study treated 76 cysts in 70 patients with symptomatic renal cysts. Aspiration and sclerotherapy was performed on 56 cysts, and 20 cysts aspirated without sclerotherapy as a control group. Treatment was performed under local anesthesia and punctured under ultrasound guidances with an 18-gauge needle. Tetracycline HCL (20%) was injected into the cystic cavity according to cyst diameter. All patients were followed up with an ultrasound examination at 3 months, 6 months, and then at yearly intervals. The reduction rate was estimated by a comparison of the volume of the cyst before and after treatment. A cyst reduction of 50% or greater in diamater was considered as a successful treatment. Results The average follow-up period was 9.8 months in the sclerotherapy group and 9.9 months in the control group. The success rate was 85.7% in the sclerotherapy group. There was a significant difference in the reduction rate of tetracycline HCL sclerotherapy group and control group. No major complications were encountered.en_US
dc.identifier.doi10.1007/s11255-007-9316-5en_US
dc.identifier.endpage613en_US
dc.identifier.issn0301-1623en_US
dc.identifier.issn1573-2584en_US
dc.identifier.issue3en_US
dc.identifier.pmid18085424en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage609en_US
dc.identifier.urihttps://dx.doi.org/10.1007/s11255-007-9316-5
dc.identifier.urihttps://hdl.handle.net/20.500.12395/22560
dc.identifier.volume40en_US
dc.identifier.wosWOS:000258063200012en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSPRINGERen_US
dc.relation.ispartofINTERNATIONAL UROLOGY AND NEPHROLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectrenal cysten_US
dc.subjectsclerotherapyen_US
dc.subjecttetracyclineen_US
dc.titlePercutaneous injection sclerotherapy with tetracycline hydrochloride in simple renal cystsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu